Inventor · disambiguated record
Mengshi Li
Also filed as: LI MENGSHI
5 granted patents·8 pending applications·15 citations·filing 2017–2024
72Inventor score
Top patents by PatentIndex Score
13 records- 0191US11576987B2Compositions and methods of treating melanomaUNIV IOWA RES FOUND·Filed 2021·Granted Feb 14, 2023·6 cites·4 claims
- 0290US11179484B2Compositions and methods of treating melanomaUNIV IOWA RES FOUND·Filed 2017·Granted Nov 23, 2021·9 cites·4 claims
- 0377US2025057914A1Compositions and methods of treating melanomaUNIV IOWA RES FOUND·Filed 2024·Application pending·0 cites
- 0476US12337042B2Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancersUNIV IOWA RES FOUND·Filed 2024·Granted Jun 24, 2025·0 cites·4 claims
- 0576US2024398891A1Compositions and methods of treating melanomaUNIV IOWA RES FOUND·Filed 2024·Application pending·0 cites
- 0671US2025009912A1Compositions for chelating metals at low temperaturesUNIV IOWA RES FOUND·Filed 2024·Application pending·0 cites
- 0766US2022072092A1Compositions and methods of treating melanomaUNIV IOWA RES FOUND·Filed 2021·Application pending·0 cites
- 0864US2025207167A1Aspergillus sp. l14-oe::laea2 and application thereof in producing cyclic tripeptidesUNIV ZHEJIANG TECHNOLOGY·Filed 2024·Application pending·0 cites
- 0961US12128115B2Compositions for chelating metals at low temperaturesUNIV IOWA RES FOUND·Filed 2019·Granted Oct 29, 2024·0 cites·7 claims
- 1061US2025186631A1Fibroblast activation protein targeting peptidesVIEWPOINT MOLECULAR TARGETING INC·Filed 2024·Application pending·0 cites
- 1160US12502442B2Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancersUNIV IOWA RES FOUND·Filed 2021·Granted Dec 23, 2025·0 cites·3 claims
- 1259US2025186630A1Fibroblast activation protein targeting peptidesVIEWPOINT MOLECULAR TARGETING INC·Filed 2023·Application pending·0 cites
- 1353US2024091705A1Removal of free-unlabeled cationic and anionic solution phase radionuclides from radiopharmaceuticals using solid-phase extraction techniquesVIEWPOINT MOLECULAR TARGETING INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mengshi Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →